The Office of Congressionally Directed Medical Research Program (CDMRP) of the Department of Defense (DoD) is funded through Congressional appropriation. The goal of the program is to transform healthcare for both service members and the general public through the funding of high-risk, high-impact research.


The National Institute of Diabetes and Digestive Kidney Diseases (NIDDK) is part of the United States National Institutes of Health. The mission of the NIDDK is to conduct and support medical research and research training and to disseminate science-based information on diabetes and other endocrine and metabolic diseases; digestive diseases, nutritional disorders, and obesity; and kidney, urologic, and hematologic diseases, to improve people’s health and quality of life.


The Child Health Evaluation and Research (CHEAR) Unit of the University of Michigan is a multidisciplinary unit bringing together faculty from pediatric subspecialties and other departments within and beyond the school of medicine. The CHEAR Unit focuses on the evaluation of child healthcare and child health programs or policies and the intersection of these with other child welfare policies.


The Fox Chase Cancer Center (FCCC) is recognized as one of the top 20 best cancer hospitals by US News and World Report for 2014-2015 and is a National Cancer Institute (NCI) designated Comprehensive Cancer Center. Joining the Temple Health System in July 2012, FCCC includes a 100 bed hospital, diagnostic services, outpatient and treatment facilities, and research center.


The Health Resources and Services Administration (HRSA) is an agency within the US Department of Health and Human Services, and is the main federal agency concerned with improving access to healthcare. HRSA operates under the following goals, including improving access to quality care and services, strengthening the health workforce, building healthy communities, and improving health equity. HRSA manages organ, bone marrow, and cord blood donation. The agency’s programs provide healthcare to vulnerable populations and supports training and research.


The National Cancer Institute (NCI) is part of the National Institutes of Health, one of 11 agencies of the US Department of Health and Human Services. NCI manages the National Cancer Program, and is engaged in and supports research, training, and health information dissemination concerning cancer causes, diagnosis, prevention, and treatment, as well as rehabilitation and continuing care for cancer patients.


The National Disease Research Interchange is the leading organization providing human tissues and organs to investigators in the US, with tissue collection sites through the country. NDRI includes three divisions: Human Tissues and Organs for Research, centered on supplying investigators with tissues and organs; the Human Biological Data Interchange, a repository housing important family and medical history information from donors; and the Special Initiatives Division, tasked with meeting new and emerging needs for human biomaterials in research.


Originally established as part of the National Institute of Health’s efforts on the International Human Genome Project, the National Human Genome Research Institute (NHGRI) today includes a broader vision of supporting research regarding the structure and function of the human genome and its role in health and disease. Additionally, NHGRI supports work examining the ethical, legal, and social implications of genome research, as well as training investigators and sharing genome information with the public and health professionals.


Authorized through the Patient Protection and Affordable Care Act of 2010, the Patient-Centered Outcomes Research Institute (PCORI) is a non-profit organization seeking to improve healthcare delivery and outcomes, as well as assist patients and their families in making informed healthcare decisions. As evidenced in its name, PCORI funds work using a patient-centered approach, directly involving patients and their families, as well as other stakeholders in healthcare, in order to support research that is most applicable to patients’ experiences in the healthcare system.


The Department of Health Behavior and Policy within Virginia Commonwealth University’s School of Medicine seeks to understand the behavioral, psychological, social, and cultural factors affecting health, as well as develop and evaluate interventions centered on these factors and translate those findings to promote positive health outcomes.

Dr. Laura Siminoff was the founding chair of the Department in 2006 and maintains close partnerships with faculty, collaborating on research concerning communication and factors influencing the delayed diagnosis of colorectal cancer, cancer health literacy, and the physical, psychological, and financial impacts of caring for someone with a later stage cancer.